Question · asked by 0 reviews

COMPARISON 1. ARIPIPRAZOLE vs OTHER ANTIPSYCHOTICS: Leaving the study early

Population
patients with schizophrenia
Intervention
COMPARISON 1. ARIPIPRAZOLE
Comparison
OTHER ANTIPSYCHOTICS
Outcome
Leaving the study early

COMPARISON 5. ARIPIPRAZOLE showed no clear difference in leaving the study early ‐ any reason compared with OTHER ANTIPSYCHOTIC DRUGS (moderate certainty).

What each review found

Current versions only
FindingEffectStudiesGRADE certainty
COMPARISON 5. ARIPIPRAZOLE vs OTHER ANTIPSYCHOTIC DRUGS
Leaving the study early ‐ any reason · patients with schizophrenia
COMPARISON 5. ARIPIPRAZOLE showed no clear difference in leaving the study early ‐ any reason compared with OTHER ANTIPSYCHOTIC DRUGS (moderate certainty).
Aripiprazole versus other atypical antipsychotics for schizophrenia (2013) · Cochrane Headline outcomes onlyearlier version CD006569.PUB4, superseded
RR 0.97 [0.78, 1.19]3 studies · 2908 participantsModerate

Findings are shown side by side, never pooled across reviews.

The reviews

ReviewSearched up toIncluded studiesAMSTAR 2
Aripiprazole versus other atypical antipsychotics for schizophrenia
2014 · Cochrane Headline outcomes only
Not reportedNot extractedNot assessed

The same intervention and outcome, asked in another population or against another comparator.

How reviews are matched to this question

Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.